InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Ianelli Christopher, 董事长兼首席执行官. Officer active across 1 company, notably iSpecimen Inc.. Cumulatively, 6 reports have been recorded. History available since 22 February 2022. The latest transaction was filed on 6 January 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Christopher Ianelli is the President and CEO of iSpecimen Inc. As the leader of the company, he oversees strategic operations and ensures growth and innovation. iSpecimen Inc. specializes in the collection and distribution of biological samples. Christopher plays a key role in developing the company's vision and objectives.